Mechanisms of Urokinase Plasminogen Activator (uPA)-mediated Atherosclerosis
Open Access
- 1 June 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (25) , 22665-22677
- https://doi.org/10.1074/jbc.m110.202135
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic CellsCirculation, 2011
- Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Level of Macrophage uPA Expression Is an Important Determinant of Atherosclerotic Lesion Growth in Apoe −/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular InjuryCirculation, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout miceProceedings of the National Academy of Sciences, 2008
- Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient miceProceedings of the National Academy of Sciences, 2008
- Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunityThe Journal of Experimental Medicine, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992